Page last updated: 2024-09-03

efonidipine and Bright Disease

efonidipine has been researched along with Bright Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akashiba, A; Ishimitsu, T; Kameda, T; Matsuoka, H; Minami, J; Numabe, A; Ohta, S; Ono, H; Takahashi, T; Yoshii, M	1

Trials

1 trial(s) available for efonidipine and Bright Disease

Article	Year
Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis. Hypertension research : official journal of the Japanese Society of Hypertension, 2007, Volume: 30, Issue:7 Topics: Adult; Aged; Aldosterone; Amlodipine; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Chronic Disease; Cross-Over Studies; Dihydropyridines; Female; Glomerulonephritis; Humans; Male; Middle Aged; Nitrophenols; Organophosphorus Compounds; Proteinuria	2007

Article

Year

Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis.

Hypertension research : official journal of the Japanese Society of Hypertension, 2007, Volume: 30, Issue:7

Topics: Adult; Aged; Aldosterone; Amlodipine; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Chronic Disease; Cross-Over Studies; Dihydropyridines; Female; Glomerulonephritis; Humans; Male; Middle Aged; Nitrophenols; Organophosphorus Compounds; Proteinuria

2007